{"id":189,"date":"2024-07-13T23:11:30","date_gmt":"2024-07-13T23:11:30","guid":{"rendered":"https:\/\/epsdco.com\/?p=189"},"modified":"2024-07-13T23:11:30","modified_gmt":"2024-07-13T23:11:30","slug":"president-biden-signs-parkinsons-bill-into-law","status":"publish","type":"post","link":"https:\/\/epsdco.com\/?p=189","title":{"rendered":"President Biden Signs Parkinson’s Bill into Law"},"content":{"rendered":"

On July 2, President Biden signed the National Plan to End Parkinson\u2019s Act into law. This is the first-ever federal legislation dedicated to ending Parkinson\u2019s disease (PD).<\/p>\n

Top five ways this monumental bill can make an impact:<\/p>\n

    \n
  1. Dramatically increase federal research funding<\/li>\n
  2. Develop more effective pathways for treatments and cures<\/li>\n
  3. Improve early diagnosis<\/li>\n
  4. Spark new and improved models for patient care<\/li>\n
  5. Address health disparities in diagnosis, treatment and clinical trial participation<\/li>\n<\/ol>\n

    \u201cThe Parkinson\u2019s Foundation is excited for what comes next,\u201d said John Lehr, Parkinson\u2019s Foundation President and CEO. \u201cWe look forward to having input in designing exactly how this bill will mobilize meaningful change for the one million Americans living with this disease.\u201d<\/p>\n

    The Parkinson\u2019s Foundation would like to thank all the PD advocates, volunteers and people who wrote to their senators and representatives to make this bill to become law. We also thank President Biden and members of the U.S. Senate and House of Representatives for helping us make PD history.<\/p>\n","protected":false},"excerpt":{"rendered":"

    On July 2, President Biden signed the National Plan to End Parkinson\u2019s Act into law. This is the first-ever federal legislation dedicated to ending Parkinson\u2019s disease (PD). Top five ways this monumental bill can make an impact: Dramatically increase federal research funding Develop more effective pathways for treatments and cures Improve early diagnosis Spark new and improved models for patient care Address health disparities in diagnosis, treatment and clinical trial participation \u201cThe Parkinson\u2019s Foundation is excited for what comes next,\u201d said John Lehr, Parkinson\u2019s Foundation President and CEO. \u201cWe look forward to having input in designing exactly how this bill<\/p>\n","protected":false},"author":1,"featured_media":190,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-189","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/epsdco.com\/index.php?rest_route=\/wp\/v2\/posts\/189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/epsdco.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/epsdco.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/epsdco.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/epsdco.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=189"}],"version-history":[{"count":1,"href":"https:\/\/epsdco.com\/index.php?rest_route=\/wp\/v2\/posts\/189\/revisions"}],"predecessor-version":[{"id":191,"href":"https:\/\/epsdco.com\/index.php?rest_route=\/wp\/v2\/posts\/189\/revisions\/191"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/epsdco.com\/index.php?rest_route=\/wp\/v2\/media\/190"}],"wp:attachment":[{"href":"https:\/\/epsdco.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/epsdco.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/epsdco.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}